Cargando…

894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea

BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with high mortality. However, most studies have focused on the short-term mortality of patients with SFTS, and little is known about long-term outcomes in patients with SFTS. METHODS: This retrospective cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Namwoo, Heo, Seok-Jae, Park, Yoon Soo, Yi, Seonju, Kim, Yong Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677267/
http://dx.doi.org/10.1093/ofid/ofad500.939
_version_ 1785150089514188800
author Heo, Namwoo
Heo, Seok-Jae
Park, Yoon Soo
Yi, Seonju
Kim, Yong Chan
author_facet Heo, Namwoo
Heo, Seok-Jae
Park, Yoon Soo
Yi, Seonju
Kim, Yong Chan
author_sort Heo, Namwoo
collection PubMed
description BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with high mortality. However, most studies have focused on the short-term mortality of patients with SFTS, and little is known about long-term outcomes in patients with SFTS. METHODS: This retrospective cohort study was conducted using the National Health Insurance Service dataset on hospitalized patients with SFTS aged ≥20 years between 2016 and 2021 (n=1,217). Each SFTS case was matched with three controls hospitalized for non-SFTS-related diseases using propensity score matching. All-cause mortality was evaluated in patients with SFTS during 1-year follow-up and compared with controls. Post-discharge events were investigated to determine the effects of SFTS on post-acute sequelae. RESULTS: Finally, 1,105 patients with SFTS and 3,315 controls were included. Patients with SFTS had a higher risk of death during the 1-year follow-up than controls (hazard ratio [HR], 2.26; 95% confidence interval [CI], 1.82–2.81). Mortality in the first 30 days was significantly higher in the SFTS group (HR, 3.99; 95% CI, 3.07–5.19) than in the control group. An increased risk of death after 31–365 days was observed in the control group; however, statistical significance was identified only in patients in their 80s (HR, 0.18; 95% CI 0.06–0.57). For the post-discharge events, the SFTS group showed a higher risk of readmission (HR, 1.17; 95% CI, 1.04–1.32) and emergency room visit (HR, 2.32; 95% CI, 1.96–2.76) than the control group. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: SFTS is associated with a higher risk of short-term mortality and post-acute sequelae in hospitalized patients during 1-year follow-up than non-SFTS-related diseases. Our results provide evidence for the management of patients with SFTS. [Figure: see text] DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677267
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106772672023-11-27 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea Heo, Namwoo Heo, Seok-Jae Park, Yoon Soo Yi, Seonju Kim, Yong Chan Open Forum Infect Dis Abstract BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with high mortality. However, most studies have focused on the short-term mortality of patients with SFTS, and little is known about long-term outcomes in patients with SFTS. METHODS: This retrospective cohort study was conducted using the National Health Insurance Service dataset on hospitalized patients with SFTS aged ≥20 years between 2016 and 2021 (n=1,217). Each SFTS case was matched with three controls hospitalized for non-SFTS-related diseases using propensity score matching. All-cause mortality was evaluated in patients with SFTS during 1-year follow-up and compared with controls. Post-discharge events were investigated to determine the effects of SFTS on post-acute sequelae. RESULTS: Finally, 1,105 patients with SFTS and 3,315 controls were included. Patients with SFTS had a higher risk of death during the 1-year follow-up than controls (hazard ratio [HR], 2.26; 95% confidence interval [CI], 1.82–2.81). Mortality in the first 30 days was significantly higher in the SFTS group (HR, 3.99; 95% CI, 3.07–5.19) than in the control group. An increased risk of death after 31–365 days was observed in the control group; however, statistical significance was identified only in patients in their 80s (HR, 0.18; 95% CI 0.06–0.57). For the post-discharge events, the SFTS group showed a higher risk of readmission (HR, 1.17; 95% CI, 1.04–1.32) and emergency room visit (HR, 2.32; 95% CI, 1.96–2.76) than the control group. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: SFTS is associated with a higher risk of short-term mortality and post-acute sequelae in hospitalized patients during 1-year follow-up than non-SFTS-related diseases. Our results provide evidence for the management of patients with SFTS. [Figure: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677267/ http://dx.doi.org/10.1093/ofid/ofad500.939 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Heo, Namwoo
Heo, Seok-Jae
Park, Yoon Soo
Yi, Seonju
Kim, Yong Chan
894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title_full 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title_fullStr 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title_full_unstemmed 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title_short 894. One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in South Korea
title_sort 894. one-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: a nationwide cohort study in south korea
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677267/
http://dx.doi.org/10.1093/ofid/ofad500.939
work_keys_str_mv AT heonamwoo 894oneyearmortalityandmorbiditiesofseverefeverwiththrombocytopeniasyndromecomparedwithotherdiseasesanationwidecohortstudyinsouthkorea
AT heoseokjae 894oneyearmortalityandmorbiditiesofseverefeverwiththrombocytopeniasyndromecomparedwithotherdiseasesanationwidecohortstudyinsouthkorea
AT parkyoonsoo 894oneyearmortalityandmorbiditiesofseverefeverwiththrombocytopeniasyndromecomparedwithotherdiseasesanationwidecohortstudyinsouthkorea
AT yiseonju 894oneyearmortalityandmorbiditiesofseverefeverwiththrombocytopeniasyndromecomparedwithotherdiseasesanationwidecohortstudyinsouthkorea
AT kimyongchan 894oneyearmortalityandmorbiditiesofseverefeverwiththrombocytopeniasyndromecomparedwithotherdiseasesanationwidecohortstudyinsouthkorea